Sep 2026· Small· pp.
e75607
· 0 citations· 43 references
Medicine
TL;DR
A simple regioselective dual-oxidation, crosslinker-free strategy for preparing hemostatic sponges is proposed, thereby offering a promising solution for rapid hemostasis and subsequent tissue repair in non-compressible wounds.
Abstract
Non-compressible hemorrhage (NCH) caused by deep tissue injury remains a major cause of trauma-related death. Developing hemostatic materials with rapid expansion, effective coagulation promotion, good biocompatibility, and tissue regeneration is still urgently needed. This study reports a simple regioselective dual-oxidation (RDO) strategy for fabricating crosslinker-free hemostatic sponges from bacterial cellulose (BC) with high porosity. Carboxyl and aldehyde groups were both introduced into the BC scaffold after TEMPO-mediated oxidation and sodium periodate oxidation. The dual-oxidation BC (DOBC) sponges retained the 3D nanofibrous architecture and rapid shape recovery, associated with aldehyde-driven hemiacetal network formation and enhanced blood interactions. Meanwhile, the sponges exhibited favorable mechanical properties, excellent biocompatibility, high liquid absorption capacity, antibacterial activity, and rapid whole-blood coagulation. Notably, DOBC sponges effectively enrich red blood cells and platelets, further promoting rapid hemostasis. In vivo studies demonstrate that DOBC sponges effectively control bleeding in rat models of NCH and outperform gauze and commercial gelatin sponges. Moreover, they promoted cell infiltration, angiogenesis, and liver tissue regeneration. This study proposes a simple dual-oxidation, crosslinker-free strategy for preparing hemostatic sponges, thereby offering a promising solution for rapid hemostasis and subsequent tissue repair in non-compressible wounds.
Massive hemorrhage and impaired wound healing continue to pose critical clinical challenges, particularly due to the limitations of currently available commercial hemostatic dressings, which often exhibit delayed clot formation, poor regenerative potential, and incomplete biodegradation, leading to secondary inflammati...
This fibrous sponge filled with BHAP and ZnO offers a potential multipurpose foundation for sophisticated hemorrhage control, and reveals a significantly lower blood clotting index than controls, confirming accelerated coagulation.
Shalini Thomas, A. Rajendran, Gosala Radha et al.· ACS Applied Bio Materials· 0 citations
Effective management of bleeding from irregular wounds requires materials with adaptability, wet adhesion and robust hemostatic capacity. We have developed a novel, self-gelling Halloysite Nanotubes/Konjac Glucomannan (HNTs/KGM) composite sponge that exhibits an in-situ sponge-to-hydrogel transition upon applicatio...
Xiao-Hui Yang, Hai-Bo Zheng, Shao-Kun Li et al.· Nano Reseach· 0 citations
While effective for irregular wounds, traditional hemostatic powders often lack posthydration cross-linking, yielding fragile barriers susceptible to washout under high-pressure hemorrhage. To address this, a novel self-gelling composite powder (GOQL) was developed by incorporating dopamine-grafted gelatin (GelDA), oxi...
Tao Liu, An-Bei Chen, Feng-Ya Jing et al.· ACS Applied Materials and In...· 0 citations
The optimized sponge demonstrated significantly superior hemostatic performance compared with a commercial gelatin sponge, achieving a hemostasis time of 3.5 s and blood loss of 80 mg, underscoring its strong potential for controlling non-compressible hemorrhage.
De-Yi Peng, Wen-Chang Zhang, Cheng-Feng Tan et al.· International Journal of Bio...· 0 citations
Most existing wound dressings provide only passive hemostasis and protection, and lack robust bio-interactions, active coagulation capabilities, or pro-healing functions, often leading to prolonged bleeding, delayed repair or recurrent bleeding. This paper describes a multifunctional spongy dressing fabricated via ther...
Xiao-Qiang Wang, Jie Li, Zhuang Shi et al.· Biomedical Materials· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.